Taiwo Oladapo

Array ( [id] => 6046613 [patent_doc_number] => 20110206658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN' [patent_app_type] => utility [patent_app_number] => 12/902434 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 118576 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206658.pdf [firstpage_image] =>[orig_patent_app_number] => 12902434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148635 [patent_doc_number] => 20110020230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'BIOMARKERS FOR PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 12/897889 [patent_app_country] => US [patent_app_date] => 2010-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10683 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020230.pdf [firstpage_image] =>[orig_patent_app_number] => 12897889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8430863 [patent_doc_number] => 20120252737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'Methods for Diagnosing and Treating Cancer' [patent_app_type] => utility [patent_app_number] => 13/499785 [patent_app_country] => US [patent_app_date] => 2010-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 32651 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054595 [patent_doc_number] => 20110110955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'ANTIBODY CANCER IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 12/886355 [patent_app_country] => US [patent_app_date] => 2010-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17801 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110955.pdf [firstpage_image] =>[orig_patent_app_number] => 12886355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5975932 [patent_doc_number] => 20110070243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC' [patent_app_type] => utility [patent_app_number] => 12/878920 [patent_app_country] => US [patent_app_date] => 2010-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 118607 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20110070243.pdf [firstpage_image] =>[orig_patent_app_number] => 12878920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6094722 [patent_doc_number] => 20110219464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'LUNG DISEASE TARGETS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/868557 [patent_app_country] => US [patent_app_date] => 2010-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 42090 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20110219464.pdf [firstpage_image] =>[orig_patent_app_number] => 12868557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070644 [patent_doc_number] => 20110045494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'CANCER DETECTION METHODS AND TECHNIQUES' [patent_app_type] => utility [patent_app_number] => 12/858964 [patent_app_country] => US [patent_app_date] => 2010-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8259 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045494.pdf [firstpage_image] =>[orig_patent_app_number] => 12858964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6119595 [patent_doc_number] => 20110076763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/858308 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15568 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076763.pdf [firstpage_image] =>[orig_patent_app_number] => 12858308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6066869 [patent_doc_number] => 20110042260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN' [patent_app_type] => utility [patent_app_number] => 12/855625 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 74210 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20110042260.pdf [firstpage_image] =>[orig_patent_app_number] => 12855625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953155 [patent_doc_number] => 20110033857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'PEPTIDE SEQUENCE THAT PROMOTES TUMER INVASION' [patent_app_type] => utility [patent_app_number] => 12/854011 [patent_app_country] => US [patent_app_date] => 2010-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15293 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033857.pdf [firstpage_image] =>[orig_patent_app_number] => 12854011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6137469 [patent_doc_number] => 20110009597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'RECOMBINANT GANODERMA LUCIDIUM IMMUNOMODULATORY PROTEIN (rLZ-8) AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/829653 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9833 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009597.pdf [firstpage_image] =>[orig_patent_app_number] => 12829653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6475786 [patent_doc_number] => 20100284975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'POLYPEPTIDES COMPRISING FAS ACTIVATION AND NKG2D-LIGAND DOMAINS' [patent_app_type] => utility [patent_app_number] => 12/826544 [patent_app_country] => US [patent_app_date] => 2010-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13443 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0284/20100284975.pdf [firstpage_image] =>[orig_patent_app_number] => 12826544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335523 [patent_doc_number] => 20120202226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => ' METHOD AND SYSTEM FOR THE DETECTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/380408 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 24204 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13380408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6580282 [patent_doc_number] => 20100291030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'USE OF IL-28 AND IL-29 TO TREAT CANCER AND AUTOIMMUNE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/818050 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 53912 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291030.pdf [firstpage_image] =>[orig_patent_app_number] => 12818050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953173 [patent_doc_number] => 20110033875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'GLYCOPROTEIN CANCER BIOMARKER' [patent_app_type] => utility [patent_app_number] => 12/814184 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 39245 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033875.pdf [firstpage_image] =>[orig_patent_app_number] => 12814184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6622762 [patent_doc_number] => 20100311084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'METHODS FOR PREDICTING A PATIENT\'S RESPONSE TO EGFR INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/795286 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10669 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311084.pdf [firstpage_image] =>[orig_patent_app_number] => 12795286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6577820 [patent_doc_number] => 20100273866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'DIAGNOSIS AND TREATMENT OF CANCER: I' [patent_app_type] => utility [patent_app_number] => 12/795268 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 31885 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273866.pdf [firstpage_image] =>[orig_patent_app_number] => 12795268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9238973 [patent_doc_number] => 08603764 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'EphA kinase cancer diagnostic' [patent_app_type] => utility [patent_app_number] => 12/795142 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 27 [patent_no_of_words] => 15628 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12795142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160039 [patent_doc_number] => 20120101003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'METHODS FOR THE DIAGNOSIS OR PROGNOSIS OF COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 13/322303 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 27246 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101003.pdf [firstpage_image] =>[orig_patent_app_number] => 13322303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817906 [patent_doc_number] => 20120064526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'KITS FOR AND METHODS OF DIFFERENTIAL STAINING OF CERVICAL CANCER CELLS AND/OR TISSUES' [patent_app_type] => utility [patent_app_number] => 13/320558 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 28511 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064526.pdf [firstpage_image] =>[orig_patent_app_number] => 13320558 [rel_patent_id] =>[rel_patent_doc_number] =>)